Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D De Sabata

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Stem Cells (Dayton, Ohio)|March 1, 1994
T suppressor activated lymphocytes (CD8+/DR+) inhibit megakaryocyte progenitor cell differentiation in a case of acquired amegakaryocytic thrombocytopenic purpuraF Benedetti, D de Sabata, G Perona
Leukemia|January 1, 1991
Soluble molecules in lymphoproliferative disordersF Vinante, L Morosato, D De Sabata, et al.
Minerva Ginecologica|November 1, 1986
[Risk and grade of feto-maternal hemotransfusion during early amniocentesis]L Spiazzi, D De Sabata, R M Tommasoli, et al.
Minerva Ginecologica|September 1, 1986
[Our experience with the significance of alpha fetoprotein levels of the amniotic fluid in prenatal diagnosis]D de Sabata, L Spiazzi, G Zamboni, et al.
Haematologica|June 1, 1991
[The immunophenotype in leukemia]G Pizzolo, F Vinante, F Benedetti, et al.
Lancet (London, England)|January 11, 1992
Determinants of HIV disease progressionG Pizzolo, F Vinante, L Morosato, et al.
AIDS (London, England)|January 1, 1992
Prognostic significance of soluble CD8 serum levels in HIV-1 infectionG Pizzolo, F Vinante, L Morosato, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
Haematologica|September 1, 1994
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosisF Vinante, L Morosato, F Siviero, et al.
International Journal of Clinical & Laboratory Research|January 1, 1993
Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of diseaseA Ambrosetti, G Nadali, F Vinante, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Stem Cells (Dayton, Ohio)|March 1, 1994
T suppressor activated lymphocytes (CD8+/DR+) inhibit megakaryocyte progenitor cell differentiation in a case of acquired amegakaryocytic thrombocytopenic purpuraF Benedetti, D de Sabata, G Perona
Leukemia|January 1, 1991
Soluble molecules in lymphoproliferative disordersF Vinante, L Morosato, D De Sabata, et al.
Minerva Ginecologica|November 1, 1986
[Risk and grade of feto-maternal hemotransfusion during early amniocentesis]L Spiazzi, D De Sabata, R M Tommasoli, et al.
Minerva Ginecologica|September 1, 1986
[Our experience with the significance of alpha fetoprotein levels of the amniotic fluid in prenatal diagnosis]D de Sabata, L Spiazzi, G Zamboni, et al.
Haematologica|June 1, 1991
[The immunophenotype in leukemia]G Pizzolo, F Vinante, F Benedetti, et al.
Lancet (London, England)|January 11, 1992
Determinants of HIV disease progressionG Pizzolo, F Vinante, L Morosato, et al.
AIDS (London, England)|January 1, 1992
Prognostic significance of soluble CD8 serum levels in HIV-1 infectionG Pizzolo, F Vinante, L Morosato, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
Haematologica|September 1, 1994
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosisF Vinante, L Morosato, F Siviero, et al.
International Journal of Clinical & Laboratory Research|January 1, 1993
Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of diseaseA Ambrosetti, G Nadali, F Vinante, et al.
Pageof 1